Why Is Celestone Soluspan So Hard to Find? [Explained for 2026]

If you or your provider has recently tried to source Celestone Soluspan — the brand-name injectable corticosteroid combining betamethasone sodium phosphate and betamethasone acetate — you may have run into roadblocks. Empty shelves, backordered vials, and frustrated clinic staff have become a familiar story for this medication. So what's actually going on, and what can you do about it?

What Is Celestone Soluspan?

Celestone Soluspan is an injectable suspension containing two forms of betamethasone: betamethasone sodium phosphate (which provides rapid onset) and betamethasone acetate (which provides sustained, extended relief). Together, they deliver both fast and long-lasting anti-inflammatory action — making this combination uniquely useful for joint injections, intrabursal injections, and intramuscular use when oral steroids aren't an option.

It has been a trusted tool in orthopedics, rheumatology, sports medicine, and allergy/immunology since its introduction in 1963. Orthopedic and sports medicine physicians in particular depend on it because it is the only multi-dose, benzyl alcohol-free glucocorticosteroid suspension currently available on the U.S. market.

Why Is Celestone Soluspan So Difficult to Find?

The supply challenges around Celestone Soluspan trace back more than two decades. In the early 2000s, the original manufacturer (then Schering-Plough, now operating under Organon) entered into a consent decree with the FDA that restricted commercial availability to instances of medical necessity only. While that specific constraint has evolved over time, it opened the door for generic competitors and complicated the supply chain.

Today, Celestone Soluspan is manufactured by Organon and a generic version (betamethasone sodium phosphate and betamethasone acetate injection) is available from manufacturers including American Regent. However, supply disruptions continue to surface. Medical supply distributors currently flag a Drug Shortage Alert Warning for this product, and availability gaps have been noted at both the retail pharmacy and clinic procurement levels.

Several structural factors keep this drug in short supply:

• Limited manufacturers. Only a small number of facilities produce the combination betamethasone suspension. Any quality issue or production slowdown at one facility ripples through the entire supply.
• Complex formulation. The dual-salt suspension is technically demanding to manufacture. Achieving the right ratio of soluble and insoluble betamethasone requires precision that limits how many facilities can produce it.
• Thin profit margins on generics. Injectable corticosteroids are typically low-cost generics. Low margins reduce incentive for manufacturers to invest in redundant production capacity, making the supply chain fragile.
• Cross-category demand spikes. When other injectable corticosteroids like methylprednisolone (Depo-Medrol) face shortages, providers switch to Celestone Soluspan as an alternative — rapidly depleting existing stock.
• Raw material and supply chain vulnerabilities. API (active pharmaceutical ingredient) sourcing for betamethasone compounds is concentrated among a small number of global suppliers, creating vulnerability to geopolitical or logistics disruptions.

Who Does the Shortage Affect Most?

Because Celestone Soluspan is administered by healthcare professionals (not self-injected at home), supply challenges primarily impact clinics, physician offices, and outpatient procedure facilities. When a clinic runs out, patients scheduled for joint injections, bursitis treatments, or corticosteroid therapy may face delays or need to switch to an alternative. For patients managing conditions like rheumatoid arthritis, bursitis, or severe allergic reactions, delays in treatment can significantly impact quality of life.

Some patients are also prescribed Celestone Soluspan for fill at retail or specialty pharmacies for certain clinic-administered protocols. In those cases, finding a pharmacy that carries it in stock can be a challenge on its own.

Is Celestone Soluspan Still Available in 2026?

Yes — Celestone Soluspan is still on the market in 2026 and is being actively manufactured and distributed by Organon. However, availability is inconsistent across pharmacies and distributors. Some locations carry it reliably while others frequently run out. The generic formulation (betamethasone sodium phosphate and betamethasone acetate injection) made by manufacturers like American Regent provides an alternative supply stream, but it too can face shortfalls.

The key challenge is not that the drug doesn't exist — it's that you need to know where to look. Supply is geographically uneven, and calling around manually can take hours.

What Should You Do If You Can't Find Celestone Soluspan?

If you have a prescription for Celestone Soluspan or your clinic is struggling to source it, here are practical steps:

1. Use a pharmacy search service. medfinder calls pharmacies near you to check which ones can fill your prescription, saving you hours of manual calling.
2. Ask about the generic. Betamethasone sodium phosphate and betamethasone acetate injection is therapeutically equivalent to Celestone Soluspan. Your prescriber may be able to write for the generic, which may be more readily available.
3. Talk to your provider about alternatives. Options like triamcinolone acetonide (Kenalog) or dexamethasone may be substitutable depending on your condition. Read our guide on alternatives to Celestone Soluspan at medfinder.com/blog/alternatives-to-celestone-soluspan-if-you-cant-fill-your-prescription.
4. Check specialty and compounding pharmacies. Some specialty pharmacies and compounding facilities maintain stock of betamethasone injectable formulations when retail pharmacies run out.

How medfinder Can Help

Instead of calling pharmacy after pharmacy hoping to get lucky, medfinder does the legwork for you. You tell us your medication, dosage, and location. We call pharmacies in your area and find out which ones have it in stock. Results are texted directly to you — no hours of hold music required.

For providers managing patients affected by supply disruptions, medfinder for Providers offers a streamlined way to help your patients find their medications quickly. Learn more at medfinder.com/blog/how-to-help-your-patients-find-celestone-soluspan-in-stock-provider-guide.

The Bottom Line

Celestone Soluspan supply disruptions are real and ongoing in 2026. The causes are structural: a complex formulation, limited manufacturers, thin margins, and cascading demand when other corticosteroids run short. But the medication is still available — you just need to know where to look. Whether you're a patient with a prescription or a provider stocking your clinic, the tools and strategies above can help you find Celestone Soluspan when your usual source comes up empty.